ArticleCPT: pharmacometrics & systems pharmacology2024

Pediatric model-based dose optimization using a pooled exposure-response safety analysis for nivolumab and nivolumab plus ipilimumab combination in melanoma.

Shengnan Du et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.